Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGPAT2 | O15120 | 1/20 | 0.42 |
| ▸ | PRKCI | P41743 | 1/20 | 0.35 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4167912 | 0.86 | ALDH1A1 (0.42) | AGPAT2HSD17B1TP53POLBMEN1 | |
| SCHEMBL13698356 | 0.81 | ALDH1A1 (0.45) | HSD17B1MAPTPOLBKMT2ALMNA | |
| SCHEMBL14426592 | 0.79 | AGPAT2 (0.51) | AGPAT2MEN1KMT2ALMNAKDM4E | |
| SCHEMBL21765854 | 0.76 | KMT2A (0.43) | AGPAT2MAPTPOLBSYKMEN1 | |
| SCHEMBL12157378 | 0.74 | AGPAT2 (0.37) | AGPAT2MAPTTP53MEN1KMT2A | |
| SCHEMBL9546363 | 0.73 | ALDH1A1 (0.47) | AGPAT2HSD17B1MAPTPOLBMEN1 | |
| SCHEMBL9444684 | 0.73 | ALOX15 (0.50) | AGPAT2MAPTPOLBMEN1KMT2A | |
| SCHEMBL24011585 | 0.71 | HSD17B1 (0.53) | AGPAT2HSD17B1TP53LMNAKDM4E | |
| SCHEMBL15378617 | 0.71 | AGPAT2 (0.50) | AGPAT2MAPTKMT2ALMNA | |
| SCHEMBL31425823 | 0.71 | HSD17B1 (0.53) | AGPAT2HSD17B1TP53LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | AXELSSON OSKAR | 2009-09-24 | — | — | US | disclosed |
| WO-2007064227-A1 | MULTIMERIC MAGENTIC RESONANCE CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | MAG, MSR1, FABP7 | AGPAT2 1071/4885PRKCI 4375/4885PRKCZ 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.